This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Tilt Biotherapeutics Oy. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Mikko Siurala: Innovator in Cancer Therapies
Introduction
Mikko Siurala is a prominent inventor based in Helsinki, Finland. He has made significant contributions to the fields of life sciences and medicine, particularly in cancer therapies. His innovative work focuses on developing advanced therapeutic methods to combat cancer in humans.
Latest Patents
Mikko Siurala holds a patent for "Oncolytic adenoviruses coding for bi-specific antibodies." This invention relates to the use of oncolytic adenoviral vectors that encode bispecific monoclonal antibodies. The patent outlines methods and applications that utilize these vectors, including their potential use in conjunction with adoptive cell therapies. He has 1 patent to his name.
Career Highlights
Siurala is associated with Tilt Biotherapeutics Oy, a company dedicated to advancing biotherapeutic solutions. His work at the company emphasizes the development of innovative cancer treatments that leverage cutting-edge technology and scientific research.
Collaborations
Mikko collaborates with notable colleagues, including Akseli Hemminki and Suvi Parviainen. Their combined expertise contributes to the advancement of cancer therapies and the exploration of new treatment methodologies.
Conclusion
Mikko Siurala is a key figure in the development of innovative cancer therapies through his patented work and collaborations. His contributions are paving the way for new treatment options in the fight against cancer.